A UK clinical trial is testing whether the dietary supplement HMB can improve strength and quality of life for cirrhosis ...

Hepatic encephalopathy is a liver disease that affects the brain. Learn how a new treatment can treat the disease and prevent ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

Dr Amir Khan has warned over a condition that affects one in five Brits - and can be caused by a range of factors with very ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

Liver cancer patients can experience many side effects during or after treatment On this World Cancer Day learn about these ...

If you have diabetes, taking steps to manage it can help prevent related health issues, including MASH. Here’s what to know to protect your liver.

The BOOST trial - led by researchers at the University of Plymouth and experts across the UK - will assess whether the Β-hydroxy β-methylbutyrate (HMB) supplement can benefit some of the 60,000 people ...

These organizations can help you educate yourself, spread awareness, and connect with the MASH community to help you better manage your health.

Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...